| 2026-10-22 17:15 |
8-K |
["3.03", "8.01", "9.01"] |
other |
0.05
|
Routine automatic conversion of Class A to common stock per IPO prospectus terms; no M&A signal. |
SEC · detail |
| 2026-09-28 17:33 |
8-K |
["1.01", "9.01"] |
material agreement |
0.15
|
Sale of 40 outpatient facilities for ~$531M; asset divestiture, not M&A activity affecting NHP. |
SEC · detail |
| 2026-09-14 07:46 |
8-K |
["5.02", "9.01"] |
officer change |
0.15
|
Board director resignation with explicit statement of no disagreement; minimal M&A signal. |
SEC · detail |
| 2026-09-10 16:30 |
8-K |
["2.01", "9.01"] |
other |
0.05
|
Asset sale transaction (30 outpatient medical facilities) by NHP; no M&A signal for company acquisition. |
SEC · detail |
| 2026-08-05 17:25 |
8-K |
["1.01"] |
material agreement |
0.15
|
Credit facility refinancing; no M&A indicators. Standard financing for working capital and acquisitions. |
SEC · detail |
| 2026-07-10 17:00 |
8-K |
["5.02", "9.01"] |
officer change |
0.15
|
CEO employment agreement extended to 2030 with auto-renewal; routine executive retention, no M&A signal. |
SEC · detail |
| 2026-06-22 16:30 |
SC TO-I |
|
tender offer |
0.15
|
Issuer self-tender offer for preferred stock redemption; not indicative of M&A activity. |
SEC · detail |
| 2026-06-17 16:30 |
SC TO-I |
|
tender offer |
0.15
|
Issuer self-tender offer for preferred stock buyback; no M&A or strategic transaction signal. |
SEC · detail |
| 2026-06-16 17:26 |
8-K |
["8.01", "9.01"] |
passive stake |
0.25
|
Mini-tender offer by MacKenzie Capital for 0.2% of shares; company remains neutral, minimal M&A signal. |
SEC · detail |
| 2026-05-18 09:28 |
SC TO-I |
|
other |
0.15
|
Issuer self-tender offer for preferred shares; not M&A-related. |
SEC · detail |
| 2026-05-18 08:30 |
8-K |
["8.01", "9.01"] |
other |
0.05
|
Company conducting self-tender offer to repurchase its own preferred stock; not M&A-related. |
SEC · detail |
| 2026-05-15 16:42 |
8-K |
["1.01", "9.01"] |
other |
0.05
|
Asset sale agreement for 86 outpatient facilities; company is seller, not acquisition target. |
SEC · detail |
| 2026-05-15 16:31 |
8-K |
["5.07", "9.01"] |
other |
0.05
|
Routine 8-K reporting 2026 annual meeting results and director elections; no M&A signals. |
SEC · detail |
| 2026-05-13 17:17 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with no M&A-related language or indicators. |
SEC · detail |
| 2026-05-08 16:36 |
8-K |
["1.01", "9.01"] |
material agreement |
0.08
|
Asset sale agreement for 86 outpatient facilities; not an M&A transaction targeting the company. |
SEC · detail |
| 2026-05-01 16:57 |
8-K |
["1.01", "5.02", "9.01"] |
other |
0.05
|
IPO-related 8-K filing covering underwritten offering completion and partnership agreement amendments; no M&A signals. |
SEC · detail |
| 2026-04-27 08:32 |
8-K |
["1.01", "9.01"] |
other |
0.05
|
Public offering of Class A common stock with underwriting agreement; no M&A signals. |
SEC · detail |